Percentage of metabolic syndrome components at baseline and the 16th week
| At baseline | At week 16 | |||||
|---|---|---|---|---|---|---|
| Intervention (n=29) | Control (n=30) | Intervention (n=2) | Control (n=30) | |||
| Metabolic syndrome component | n(%) | n(%) | χ2 test p-value | n(%) | n(%) | χ2 test p-value |
| Number of ATP III criteriaa | ||||||
| <3 | 18(42.1) | 17(56.7) | 0.810 | 24(82.7) | 16(53.3) | 0.016* |
| ⩾3 | 11(37.9) | 13(43.3) | 5(17.3) | 14(46.7) | ||
| At baseline | At week 16 | |||||
|---|---|---|---|---|---|---|
| Intervention ( | Control ( | Intervention ( | Control ( | |||
| Metabolic syndrome component | ||||||
| <3 | 18(42.1) | 17(56.7) | 0.810 | 24(82.7) | 16(53.3) | 0.016* |
| ⩾3 | 11(37.9) | 13(43.3) | 5(17.3) | 14(46.7) | ||
Notes: aWaist circumference ⩾80 cm (Asian cutoff point for females), Fasting blood sugar ⩾100 mg/dl, Triglyceride ⩾150 mg/dl, High density lipoprotein cholesterol <50 mg/dl, Blood pressure ⩾130/⩾85 mg/dl; The metabolic syndrome diagnosis is ⩾3 of 5 criteria; ATP III National Cholesterol Education-Adult Treatment Panel III. *p<0.05
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.